Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras (CALLAS)

National Cancer Institute, Naples

Status: Active, not recruiting

Conditions: Metastatic Colorectal Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01651013

CALLAS

Details and patient eligibility

About

The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologic diagnosis colorectal carcinoma
• Metastatic disease
• Signed informed consent

Exclusion criteria

• Prior treatment of metastatic colorectal cancer
• Refusal or incapability of providing informed consent

Trial design

500 participants in 1 patient group

metastatic colorectal cancer